The emerging role of lactate in tumor microenvironment and its clinical relevance
- PMID: 38548215
- DOI: 10.1016/j.canlet.2024.216837
The emerging role of lactate in tumor microenvironment and its clinical relevance
Abstract
In recent years, the significant impact of lactate in the tumor microenvironment has been greatly documented. Acting not only as an energy substance in tumor metabolism, lactate is also an imperative signaling molecule. It plays key roles in metabolic remodeling, protein lactylation, immunosuppression, drug resistance, epigenetics and tumor metastasis, which has a tight relation with cancer patients' poor prognosis. This review illustrates the roles lactate plays in different aspects of tumor progression and drug resistance. From the comprehensive effects that lactate has on tumor metabolism and tumor immunity, the therapeutic targets related to it are expected to bring new hope for cancer therapy.
Keywords: Drug resistance; Lactic acid; Lactylation; Metabolic symbiosis; Tumor progression.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflict of interest.
Similar articles
-
Lactylation in cancer progression and drug resistance.Drug Resist Updat. 2025 Jul;81:101248. doi: 10.1016/j.drup.2025.101248. Epub 2025 Apr 21. Drug Resist Updat. 2025. PMID: 40287994 Review.
-
Research progress on the regulatory role of lactate and lactylation in tumor microenvironment.Biochim Biophys Acta Rev Cancer. 2025 Jul;1880(3):189339. doi: 10.1016/j.bbcan.2025.189339. Epub 2025 Apr 29. Biochim Biophys Acta Rev Cancer. 2025. PMID: 40311713 Review.
-
Lactylation in tumor microenvironment and immunotherapy resistance: New mechanisms and challenges.Cancer Lett. 2025 Sep 1;627:217835. doi: 10.1016/j.canlet.2025.217835. Epub 2025 May 28. Cancer Lett. 2025. PMID: 40447130 Review.
-
Lactate and lactylation in liver diseases: energy metabolism, inflammatory immunity and tumor microenvironment.Front Immunol. 2025 May 12;16:1581582. doi: 10.3389/fimmu.2025.1581582. eCollection 2025. Front Immunol. 2025. PMID: 40421024 Free PMC article. Review.
-
Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.Int J Mol Sci. 2022 Oct 8;23(19):11943. doi: 10.3390/ijms231911943. Int J Mol Sci. 2022. PMID: 36233246 Free PMC article. Review.
Cited by
-
Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity.J Immunother Cancer. 2024 Dec 4;12(12):e009768. doi: 10.1136/jitc-2024-009768. J Immunother Cancer. 2024. PMID: 39631851 Free PMC article.
-
Tumor energy metabolism: implications for therapeutic targets.Mol Biomed. 2024 Nov 29;5(1):63. doi: 10.1186/s43556-024-00229-4. Mol Biomed. 2024. PMID: 39609317 Free PMC article. Review.
-
Potential of lactylation as a therapeutic target in cancer treatment (Review).Mol Med Rep. 2025 Apr;31(4):91. doi: 10.3892/mmr.2025.13456. Epub 2025 Feb 14. Mol Med Rep. 2025. PMID: 39950331 Free PMC article. Review.
-
Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma.J Clin Invest. 2025 Apr 1;135(7):e191422. doi: 10.1172/JCI191422. J Clin Invest. 2025. PMID: 40166931 Free PMC article.
-
H3 lysine 18 lactylation-mediated RRAS2 facilitates migration and invasion of head and neck squamous cell carcinoma.Sci Rep. 2025 Jul 1;15(1):21282. doi: 10.1038/s41598-025-04233-8. Sci Rep. 2025. PMID: 40594208 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical